Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

3.8%

12 terminated/withdrawn out of 312 trials

Success Rate

95.2%

+8.7% vs industry average

Late-Stage Pipeline

9 trials in Phase 3/4

Results Transparency

15%

35 of 239 completed trials have results

Key Signals

31 recruiting35 with results8 withdrawn

Enrollment Performance

Analytics

N/A

98(75.4%)

Phase 2

10(7.7%)

Phase 1

7(5.4%)

Phase 3

6(4.6%)

Early Phase 1

6(4.6%)

Phase 4

3(2.3%)

130Total

N/A(98)

Phase 2(10)

Phase 1(7)

Phase 3(6)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (312)

Showing 20 of 312 trials

NCT05160948Completed

Change in Knowledge After Receiving Personal Air Pollution Results

Role: collaborator

NCT06991751Not Yet Recruiting

A Natural History of Cardiometabolic Disease Among US Bhutanese: Developing the Cross-Sectional Bhutanese Community of Central Ohio Health Study to Understand Acculturation as Synergizing Socioenvironmental and Biobehavioral Risk Factors Propagating ...

Role: lead

NCT07566481Not Yet Recruiting

Stress, Coping, and Sleep Health Study

Role: lead

NCT07111065Phase 2Recruiting

FAST for DM - Fatty Acid Supplementation Trial (FAST) for Dermatomyositis (DM)

Role: lead

NCT07437976Not Yet Recruiting

A Natural History of Genetic and Environmental Predictors of Pubertal Timing Among Youth With Obesity

Role: lead

NCT01678222Completed

The COX-2 Gene and the Immune System